X Bertagna
Overview
Explore the profile of X Bertagna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
2078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertagna X, Boudou-Rouquette P, Alexandre J, Soubrane O, Goldwasser F
Ann Oncol
. 2020 Jun;
20(12):2019.
PMID: 32560025
No abstract available.
2.
Bertagna X
Eur J Endocrinol
. 2018 Feb;
178(5):R183-R200.
PMID: 29467229
One of today's challenges in endocrinology is the treatment of Cushing's disease: Although pituitary surgery has the potential to 'cure' the patient and restore a completely normal pituitary adrenal axis,...
3.
Belmihoub I, Silvera S, Sibony M, Dousset B, Legmann P, Bertagna X, et al.
Eur J Endocrinol
. 2017 Mar;
176(6):K15-K19.
PMID: 28348073
New European guidelines for the management of adrenal incidentalomas were recently released. One of the most novel recommendations is to stop following patients when they present a typical, small and...
4.
Goudet P, Dalac A, Le Bras M, Cardot-Bauters C, Niccoli P, Levy-Bohbot N, et al.
J Clin Endocrinol Metab
. 2015 Jan;
100(4):1568-77.
PMID: 25594862
Context: Multiple endocrine neoplasia Type-1 (MEN1) in young patients is only described by case reports. Objective: To improve the knowledge of MEN1 natural history before 21 years old. Methods: Obtain...
5.
Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, et al.
Endocr Relat Cancer
. 2013 Jun;
20(4):579-94.
PMID: 23756429
Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis. Local and distant recurrences occur in a subset of tumors classified as 'aggressive' ACC (aACC), as opposed to 'non-aggressive' ACC...
6.
Ederhy S, Cohen A, Dufaitre G, Chaderevian R, Abbas H, Bertagna X, et al.
J Endocrinol Invest
. 2012 Sep;
35(10):911-4.
PMID: 23013780
Objective: We designed a single-center retrospective study to assess the QT interval duration and to describe cardio vascular events among patients treated with mitotane for a adrenocortical carcinoma (ACC). Design:...
7.
Gaujoux S, Bonnet S, Leconte M, Zohar S, Bertherat J, Bertagna X, et al.
Br J Surg
. 2011 May;
98(10):1392-9.
PMID: 21618212
Background: Laparoscopic adrenalectomy (LA) is the procedure of choice for surgical management of most benign adrenal tumours, with a reported overall complication rate around 10 per cent. The aim of...
8.
Latrech H, Rousseau A, le Marois E, Billaud L, Bertagna X, Azzoug S, et al.
Rev Med Interne
. 2010 Nov;
31(12):858-62.
PMID: 21074296
Introduction: Among pituitary adenomas, thyrotropinomas were previously considered as extremely rare and resistant to therapy. However, the common use of the sensitive TSH measurement and the improvement of pituitary imaging...
9.
Boudou-Rouquette P, Alexandre J, Soubrane O, Bertagna X, Goldwasser F
Ann Oncol
. 2009 Jul;
20(10):1747.
PMID: 19633056
No abstract available.
10.
Fulla Y, BONNICHON P, Tissier F, Delbot T, Richard B, Bertagna X, et al.
J Radiol
. 2009 May;
90(3 Pt 2):413-21.
PMID: 19421132
The diagnosis of primary hyperparathyroidism (PHP) is chemical: high level of Parathormone (PTH) in conjunction with hypercalcaemia. In borderline cases with sub-normal plasma PTH and calcium, an oral calcium load...